Categories AlphaGraphs, Earnings, Health Care
BMY Earnings: Bristol-Myers Squibb reports higher Q2 revenue and profit
Biotechnology company Bristol Myers Squibb (NYSE: BMY) Friday reported higher revenues and net profit for the second quarter of 2024.
Net income attributable to shareholders was $1.68 billion or $0.83 per share in the June quarter, compared to $2.07 billion or $0.99 per share in the comparable period of 2023. Adjusted profit rose to $2.07 per share in Q2 from $1.75 per share in the prior year period.
Second-quarter revenues increased 9% from last year to $12.2 billion. Domestic revenues increased by 13%, while international revenues edged down 1%.
Prior Performance
Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.
Most Popular
Earnings Preview: Accenture (ACN) likely had a strong start to fiscal 2025
For Accenture plc. (NYSE: ACN), 2024 was a fruitful year marked by positive financial performance. The professional service firm effectively navigated a challenging market environment leveraging its agile business model
Signet Jewelers (SIG): Fashion remains a strong point for the jewelery retailer
Shares of Signet Jewelers Limited (NYSE: SIG) were down over 3% on Tuesday. The stock has dropped 12% over the past three months. The company faced challenges in the third
Pfizer (PFE) reaffirms FY24 forecast; provides FY25 guidance
Pharmaceutical company Pfizer Inc. (NYSE: PFE) Tuesday reaffirmed its financial outlook for fiscal 2024 and provided guidance for fiscal 2025. The company said it achieved the goal of $4 bln
